The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer
B Waissengrin, T Zahavi, M Salmon-Divon, Alexander A. Goldberg et autres
BACKGROUND: An effect of non-oncology medications on cancer outcome has been proposed. In this study, we aimed to systematically examine the impact of commonly prescribed non-oncology drugs on clinical risk and on the genomic risk [based on the Oncotype DX recurrence score …
il, us (code pays fourni par la source)